Examkin

Question

Difficulty: EasyGynecologic Oncology

A 35-year-old premenopausal woman, gravida 2, para 2, presents to her gynecologist for routine health maintenance. She has no active complaints, and her past medical history is unremarkable. Speculum examination reveals a normal-appearing cervix with no gross lesions. Arrange the following events in the standard sequential clinical pathway, from her initial screening abnormality to the definitive management of high-grade cervical dysplasia.

  1. 1Routine cervical cytology reporting Atypical Squamous Cells of Undetermined Significance (ASC-US)
  2. 2Reflex testing of the specimen returning positive for high-risk human papillomavirus (hrHPV)
  3. 3Colposcopic examination with directed biopsies confirming Cervical Intraepithelial Neoplasia grade 3 (CIN 3)
  4. 4Loop electrosurgical excision procedure (LEEP) to excise the cervical transformation zone

Answer

The correct sequence begins with an ASC-US cytology result, followed by positive reflex hrHPV testing, leading to a colposcopy with biopsy confirming CIN 3, and concluding with a LEEP for definitive treatment.
The algorithm for cervical cancer screening and prevention follows a stepwise approach from screening to definitive diagnosis and subsequent treatment. In a 35-year-old woman, an initial screening cytology showing Atypical Squamous Cells of Undetermined Significance (ASC-US) requires triage to determine the risk of underlying high-grade dysplasia. The preferred triage method is reflex testing for high-risk HPV. If the hrHPV test is positive, the patient's risk for significant dysplasia is elevated, mandating colposcopy for direct visualization and directed biopsies. Once a tissue diagnosis of a high-grade lesion like CIN 3 is confirmed via biopsy, definitive excisional treatment, such as a Loop Electrosurgical Excision Procedure (LEEP), is required to remove the transformation zone and prevent progression to invasive cervical cancer.

Step-by-Step Solution

1
Identify the initial screening abnormality.
The clinical pathway begins with an indeterminate cytology result of ASC-US.
ASC-US requires triage to determine the patient's risk of underlying high-grade dysplasia.
2
Determine the appropriate triage step for ASC-US.
Reflex testing for high-risk HPV.
Current guidelines recommend hrHPV testing to stratify risk; a positive result indicates a higher risk for significant dysplasia and the need for further diagnostic workup.
3
Identify the next diagnostic step following a positive triage result.
Colposcopy with directed biopsies.
Direct visualization and targeted tissue sampling are required to definitively diagnose the presence and severity of cervical dysplasia.
4
Determine the definitive management for the confirmed high-grade lesion.
Excisional procedure such as LEEP.
CIN 3 is a high-grade precancerous lesion with significant malignant potential that must be removed to prevent progression to invasive cervical cancer.

Key Concept

Algorithmic clinical pathway for the evaluation and management of abnormal cervical cancer screening (ASC-US to CIN 3).
Estimated Time:1m 0s
Rate this question

Topics

Gynecologic Oncology

More questions from this topic